Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Tadao Ishida

Showing results (31-40 of 151) with videos related to

Pageof 16
Sort By:
American Journal of Hematology|January 1, 2003
Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndromeHiroshi Yasui, Yasushi Adachi, Takae Minami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma]Yumiko Maruyama, Toshiaki Hayashi, Hiroshi Ikeda, et al.
Future Oncology (London, England)|November 4, 2022
Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in JapanShinsuke Iida, Mayuko Nakakoji, Dionysis Spanopoulos, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 9, 2014
Allogeneic bone marrow transplantation in a patient with primary hepatic diffuse large B-cell lymphoma that relapsed after autologous stem cell transplantationKazuya Ishiguro, Toshiaki Hayashi, Yuka Aoki, et al.
International Journal of Hematology|October 16, 2020
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) - a focus on healthcare resource utilization and costShinsuke Iida, Tadao Ishida, Katsuhisa Horimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 28, 2012
[Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation]Tetsuyuki Igarashi, Toshiaki Hayashi, Hiroshi Yasui, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 23, 2005
A case-control study of multiple myeloma in Japan: association with occupational factorsTomoko Sonoda, Tadao Ishida, Masamitsu Mori, et al.
International Journal of Hematology|April 6, 2019
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM)Shinsuke Iida, Tadao Ishida, Hirokazu Murakami, et al.
International Journal of Hematology|May 29, 2015
Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosisKazuya Ishiguro, Toshiaki Hayashi, Tetsuyuki Igarashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 28, 2021
Spinal Cord Infarction in a Patient with Immune Thrombocytopenic PurpuraKenta Orimo, Mizuki Ogura, Keiko Hatano, et al.
Pageof 16

Showing results (31-40 of 151) with videos related to

Sort By:
Pageof 16
American Journal of Hematology|January 1, 2003
Combination therapy of DDAVP and conjugated estrogens for a recurrent large subcutaneous hematoma in Ehlers-Danlos syndromeHiroshi Yasui, Yasushi Adachi, Takae Minami, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|February 9, 2013
[Usefulness of serum free light-chain assay for evaluation of therapeutic efficacy in non-secretory multiple myeloma]Yumiko Maruyama, Toshiaki Hayashi, Hiroshi Ikeda, et al.
Future Oncology (London, England)|November 4, 2022
Practice patterns and outcomes for triple-class exposed patients with relapsed/refractory multiple myeloma in JapanShinsuke Iida, Mayuko Nakakoji, Dionysis Spanopoulos, et al.
Nihon Shokakibyo Gakkai Zasshi = the Japanese Journal of Gastro-Enterology|September 9, 2014
Allogeneic bone marrow transplantation in a patient with primary hepatic diffuse large B-cell lymphoma that relapsed after autologous stem cell transplantationKazuya Ishiguro, Toshiaki Hayashi, Yuka Aoki, et al.
International Journal of Hematology|October 16, 2020
Medical database analysis of japanese multiple myeloma patients with planned stem cell transplantation (MEDALIST) - a focus on healthcare resource utilization and costShinsuke Iida, Tadao Ishida, Katsuhisa Horimoto, et al.
[Rinsho Ketsueki] the Japanese Journal of Clinical Hematology|March 28, 2012
[Sustained complete molecular remission after cessation of imatinib mesylate treatment in a patient with relapsed chronic myelogenous leukemia after allogeneic stem cell transplantation]Tetsuyuki Igarashi, Toshiaki Hayashi, Hiroshi Yasui, et al.
Asian Pacific Journal of Cancer Prevention : APJCP|March 23, 2005
A case-control study of multiple myeloma in Japan: association with occupational factorsTomoko Sonoda, Tadao Ishida, Masamitsu Mori, et al.
International Journal of Hematology|April 6, 2019
JSH practical guidelines for hematological malignancies, 2018: III. Myeloma-1. Multiple myeloma (MM)Shinsuke Iida, Tadao Ishida, Hirokazu Murakami, et al.
International Journal of Hematology|May 29, 2015
Decrease of B-type natriuretic peptide to less than 200 pg/mL predicts longer survival in cardiac immunoglobulin light chain amyloidosisKazuya Ishiguro, Toshiaki Hayashi, Tetsuyuki Igarashi, et al.
Journal of Stroke and Cerebrovascular Diseases : the Official Journal of National Stroke Association|January 28, 2021
Spinal Cord Infarction in a Patient with Immune Thrombocytopenic PurpuraKenta Orimo, Mizuki Ogura, Keiko Hatano, et al.
Pageof 16